Sample · abbreviated deliverable

H001 — evidence summary

Pre-registered daily BTC/USDT trend hypothesis (Donchian + ATR trail, long-only, EMA filter). Full experiment report on disk: H001_20260810T082405Z (research lab, Aug 2026).

Evidence verdict: insufficient for live capital

Context (locked before OOS)

Symbol / TFBTC/USDT · 1d · Binance spot (public OHLCV)
Cost model10 bps fee + 5 bps slippage per side (pre-registered)
Walk-forward730 train / 180 test bars, step 180
Null test100 permutations, pass if OOS PnL > 95th percentile of null
Min OOS trades gate≥ 15 (pre-registered)

OOS combined (from report)

Trades13
Expectancy / trade8.76 (currency units on 1,000 start)
Total OOS PnL113.92
Win rate46.15%
Profit factor2.48
Max DD (trade equity path)−1.95%

Raw OOS metrics can look acceptable. Gates still failed — see below.

Gate results

oos_expectancy_gt_0PASS
oos_total_pnl_gt_0PASS
null_test_passFAIL — observed 113.9 < threshold 455.5; null mean 148.8
sample_adequateFAIL — 13 trades < 15 required

Five primary evidence risks (example format)

  1. Null test failure: OOS PnL is not distinguishable from shuffled-return null at the pre-registered bar — path/luck not ruled out.
  2. Under-powered OOS sample: 13 trades vs 15 minimum; fold 7 had zero trades.
  3. Fold instability: fold_1 negative expectancy (−6.51/trade) while other folds positive — fragile period dependence.
  4. Interpretation risk: headline OOS PnL invites live deployment without null/sample gates.
  5. Execution gap: daily spot backtest ≠ guaranteed fills/slippage in live; not modeled beyond fixed bps.

Recommended next experiment (scope only)

Do not tune H001 parameters on this OOS. Either archive hypothesis or open a new ID with pre-registered changes. If continuing trend family: lengthen history requirement or tighten null test before any paper trading — still no live capital until all gates pass.

This page is a marketing sample, not a client deliverable. Numbers are copied from the archived experiment report only. No performance promise is made for any strategy.

Buy the founding review — €79

Legal · Privacy · Terms